← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tempo Therapeutics, Inc.
San Diego, CA
$4,373,147
Total funding
3
Grants
Funding over time
peak $1.4M · FY2016–22$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,373,147 · 3
By mechanism
R44$4,148,148 · 2
R43$224,999 · 1
Investigators at Tempo Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients$1,368,090
R44 · FY2021 · DK
A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients$1,181,406
R44 · FY2022 · DK
MAP: a Flowable, Precision-Engineered, and Tunable Tissue Scaffold Leveraging Hyper-Porous Geometry to Control Inflammation and Promote Regenerative Healing in Diabetic Wounds$836,914
R44 · FY2020 · DK
MAP: a Flowable, Precision-Engineered, and Tunable Tissue Scaffold Leveraging Hyper-Porous Geometry to Control Inflammation and Promote Regenerative Healing in Diabetic Wounds$737,053
R44 · FY2019 · DK
A flowable microporous biomaterial as a low cost, high efficacy diabetic chronic ulcer treatment$224,999
R43 · FY2016 · DK
Diversity supplement for Oliver Viyar to receive research training in tissue engineering.$24,685
R44 · FY2020 · DK